GlassScriptPhysician profile
Turkan Ozcan
NPI 1528597119
$1,696.21
in general payments reported to CMS, 2019-2025
20 companies · $557 in 2025
The $557 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $133 · 2022: $323 · 2023: $136 · 2024: $548 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,241.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $428.29 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $281.09 | 2021-2025 | |
| Amgen INC. | $245.48 | 2023-2025 | Evenity |
| Lilly USA, LLC | $153.02 | 2022-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $121.88 | 2022-2024 | |
| Glaxosmithkline, LLC. | $97.70 | 2022-2025 | Trelegy Ellipta, Arexvy |
| Biomarin Pharmaceutical INC. | $47.45 | 2024 | Voxzogo 1.2mg |
| Pfizer INC. | $46.53 | 2022-2024 | |
| Cipher Pharmaceuticals US LLC | $36.85 | 2025 | Natroba, Spinosad |
| Merck Sharp & Dohme LLC | $34.28 | 2021 | |
| Phathom Pharmaceuticals, INC. | $33.64 | 2025 | Voquezna |
| Dexcom, INC. | $24.54 | 2024 | Dexcom G6 Transmitter |
| Shield Therapeutics INC | $24.30 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.11 | 2021 | |
| Sanofi-Aventis U.S. LLC | $19.08 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $18.71 | 2024 | Vyepti |
| Novartis Pharmaceuticals Corporation | $18.08 | 2025 | |
| Smith+Nephew, INC. | $16.82 | 2024 | Collagenase Santyl |
| Exact Sciences Corporation | $16.07 | 2024 | Cologuard Collection Kit |
| Medtronic, INC. | $12.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Turkan Ozcan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.